Barbara Ensoli Selected Research

Barbara Ensoli Research Topics

Disease

38	Infections 06/2020 - 09/2002
28	Acquired Immunodeficiency Syndrome (AIDS) 02/2022 - 04/2002
13	Disease Progression 08/2019 - 10/2004
12	Kaposi Sarcoma (Kaposi's Sarcoma) 02/2022 - 03/2002
12	Neoplasms (Cancer) 02/2022 - 07/2002
7	HIV Infections (HIV Infection) 01/2024 - 05/2005
6	Viremia 01/2019 - 04/2007
5	Virus Diseases (Viral Diseases) 02/2008 - 12/2003
4	Carcinoma (Carcinomatosis) 12/2020 - 05/2012
3	Uterine Cervical Dysplasia 12/2020 - 05/2012
2	Tuberculosis (Tuberculoses) 01/2016 - 09/2006
1	Chronic Disease (Chronic Diseases) 01/2022
1	Reinfection 06/2020
1	Asymptomatic Diseases 06/2016
1	Lentivirus Infections 01/2014
1	Adenocarcinoma 01/2011
1	Atherosclerosis 06/2010
1	Vesicular Stomatitis 11/2009
1	Herpes Simplex 11/2006
1	Inflammation (Inflammations) 09/2003
1	Lymphoma (Lymphomas) 09/2003
1	Neoplasm Metastasis (Metastasis) 09/2003
1	Latent Infection 10/2002
1	Herpesviridae Infections (Herpesvirus Infection) 07/2002

Drug/Important Bio-Agent (IBA)

29	VaccinesIBA 02/2022 - 09/2002
15	tat Gene Products (tat Protein)IBA 01/2024 - 04/2002
11	HIV Protease InhibitorsIBA 12/2020 - 03/2002
10	AntibodiesIBA 02/2022 - 04/2005
10	Proteins (Proteins, Gene)FDA Link 05/2018 - 09/2004
8	CytokinesIBA 02/2022 - 11/2002
6	Saquinavir (Invirase)FDA Link 12/2020 - 08/2003
6	Indinavir (Crixivan)FDA Link 12/2020 - 08/2003
5	Matrix Metalloproteinases (MMPs)IBA 12/2020 - 01/2011
5	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 09/2004
4	Ritonavir (Norvir)FDA Link 12/2020 - 09/2003
4	Trans-Activators (Trans-Acting Factor)IBA 10/2016 - 04/2006
4	Antiviral Agents (Antivirals)IBA 01/2014 - 12/2003
4	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 01/2011 - 02/2009
3	Immunoglobulin G (IgG)IBA 01/2016 - 01/2014
3	AntigensIBA 01/2008 - 09/2002
3	Viral AntigensIBA 11/2006 - 07/2002
2	InterferonsIBA 01/2016 - 12/2003
2	Virulence Factors (Pathogenicity Factors)IBA 01/2015 - 06/2014
2	IntegrinsIBA 06/2014 - 01/2012
2	Biomarkers (Surrogate Marker)IBA 01/2014 - 02/2009
2	Angiogenesis Inducing Agents (Angiogenesis Factor)IBA 08/2011 - 11/2002
2	Protease Inhibitors (Protease Inhibitor)IBA 01/2011 - 09/2003
2	Telomerase (Telomerase Reverse Transcriptase)IBA 11/2010 - 07/2010
2	EpitopesIBA 01/2008 - 07/2002
2	AIDS VaccinesIBA 03/2007 - 11/2006
1	Lopinavir FDA Link 12/2020
1	Estrogens (Estrogen)FDA Link 12/2020
1	Tissue Inhibitor of Metalloproteinase-3IBA 12/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 12/2020
1	Therapeutic UsesIBA 06/2020
1	Viral RNAIBA 12/2018
1	Peptide Hydrolases (Proteases)FDA Link 05/2018
1	CC ChemokinesIBA 01/2016
1	Immunoglobulin M (IgM)IBA 01/2016
1	Immunoglobulin A (IgA)IBA 01/2016
1	Matrix Metalloproteinase 14 (MT1-MMP)IBA 10/2014
1	DefensinsIBA 01/2014
1	Interleukin-10 (Interleukin 10)IBA 01/2014
1	Herpes Simplex Virus VaccinesIBA 01/2014
1	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2011
1	RNA (Ribonucleic Acid)IBA 11/2010
1	Dihydrotachysterol (AT 10)IBA 09/2010
1	RibonucleoproteinsIBA 07/2010
1	Glycoproteins (Glycoprotein)IBA 11/2009
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 04/2008
1	gag Gene Products (gag Protein)IBA 01/2008
1	Natural Killer Cell ReceptorsIBA 05/2005
1	NF-kappa B (NF-kB)IBA 12/2004
1	Interleukin-2 (IL2)IBA 04/2004
1	Interleukin-4 (Interleukin 4)IBA 04/2004
1	Nelfinavir (Viracept)FDA Link 09/2003
1	EnzymesIBA 02/2003
1	Human immunodeficiency virus 1 p16 proteaseIBA 03/2002

Therapy/Procedure

8	Therapeutics 02/2022 - 11/2002
8	Highly Active Antiretroviral Therapy (HAART) 01/2022 - 10/2002
1	Art Therapy 01/2015
1	Microspheres (Microsphere) 01/2014
1	Aftercare (After-Treatment) 10/2002